首页> 美国卫生研究院文献>Journal of Atherosclerosis and Thrombosis >Comparison of the OUTBACK® Elite Reentry Catheter and the Bi-directional Approach after Failed Antegrade Approach for Femoro-popliteal Occlusive Disease
【2h】

Comparison of the OUTBACK® Elite Reentry Catheter and the Bi-directional Approach after Failed Antegrade Approach for Femoro-popliteal Occlusive Disease

机译:OUTBACK®精英折返导管与股An动脉闭塞性疾病失败融合后双向入路的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aim: A successful antegrade wire crossing for femoro-popliteal chronic total occlusion (FP-CTO) is still a technical challenge. We attempted to demonstrate the safety and feasibility of the OUTBACK® Elite reentry catheter and the bi-directional approach for failed FP-CTO cases with the antegrade approach.>Methods: Endovascular therapy for FP-CTO was performed in 219 lesions from May 2013 to December 2016 at Morinomiya Hospital. We retrospectively analyzed the data of 43 consecutive lesions which underwent endovascular therapy using the bi-directional approach with distal access and the mono-directional approach with the OUTBACK® Elite reentry catheter for FP-CTO lesions. The antegrade success using a combination of traditional and Intravascular Ultrasound (IVUS) -guided techniques was achieved in 170 lesions out of a total of 219 lesions. From May 2013 to June 2016 (phase 1), the bi-directional approach with distal access was applied to 22 lesions after failed antegrade approaches. From July 2016 to December 2016 (phase 2), the mono-directional approach with the OUTBACK® Elite reentry catheter was applied to 21 lesions.>Results: Clinical and lesion characteristics in phase 1 were not significantly different from those in phase 2. The overall initial technical success rate was 100% in both phases. The total wire number and amount of contrast media were significantly less, and the total procedure time and the total fluoroscopic time were significantly shorter in phase 2 than in phase 1 (p < 0.01).>Conclusions: Endovascular therapy for FP-CTO using the OUTBACK® Elite reentry catheter is feasible and safe after a failed antegrade approach.
机译:>目标:成功完成股pop慢性慢性完全闭塞(FP-CTO)的顺行穿线仍是一项技术挑战。我们试图通过顺行方法证明OUTBACK ® Elite再入导管和双向入路治疗失败的FP-CTO病例的安全性和可行性。>方法: 2013年5月至2016年12月,在森之宫医院对219个病变进行了FP-CTO的检查。我们回顾性分析了43例连续病变的数据,这些病变采用双向远端入路和OUTBACK ® Elite再入导管对FP-CTO病变进行了血管内治疗。使用传统和血管内超声(IVUS)引导技术相结合的顺行性成功在总共219个病灶中的170个病灶中获得了成功。从2013年5月至2016年6月(第1阶段),顺行入路失败后,对22个病变采用了远端入路的双向入路。从2016年7月至2016年12月(第二阶段),采用OUTBACK ® Elite再入导管的单向方法治疗了21个病变。>结果:第一阶段与第二阶段没有显着差异。两个阶段的总体初始技术成功率为100%。与第一阶段相比,第二阶段的总导线数量和造影剂数量显着减少,总手术时间和透视时间明显缩短(p <0.01)。>结论:顺行入路失败后,使用OUTBACK ®进行FP-CTO的Elite再入导管既可行又安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号